Omeros reported $312.58M in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acelrx Pharmaceuticals ACRX:US $ 9.37M 1.89M
Adma Biologics ADMA:US $ 93.88M 0.46M
Aerie Pharmaceuticals AERI:US $ 222.02M 5.94M
Alexion Pharmaceuticals ALXN:US $ 2388.8M 30.8M
Alnylam Pharmaceuticals ALNY:US $ 433.15M 241.56M
Biomarin Pharmaceutical BMRN:US $ 1077.11M 0.98M
Cytokinetics CYTK:US $ 127.89M 3.88M
Dynavax Technologies DVAX:US $ 219.96M 40.07M
Heron Therapeutics HRTX:US $ 148.98M 148.98M
Insmed INSM:US $ 562.86M 186.87M
Intercept Pharmaceuticals ICPT:US $ 575.82M 7.7M
Knight Therapeutics Inc GUD:CN C$ 2.89M 720K
Macrogenics MGNX:US $ 0 0
Mirati Therapeutics MRTX:US $ 0M 0M
Omeros OMER:US $ 312.58M 426K
Pacira Pharmaceuticals PCRX:US $ 321.71M 4.37M
Rockwell Medical RMTI:US $ 0M 21.04M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1092.98M 1.88M
United Therapeutics UTHR:US $ 800M 0M
Vertex Pharmaceuticals VRTX:US $ 524.92M 5.4M
Vital Therapies VTL:US $ 0M 0M
Xoma XOMA:US $ 0 11.65M